Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia

It was previously reported that PRR34‐AS1 was overexpressed in some solid tumors. PRR34‐AS1 promoter was shown to have a differential methylation region (DMR), and was hypomethylated in acute myeloid leukemia (AML). Therefore, the present study used real‐time quantitative PCR (RQ‐PCR) to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Fang‐yu, Gu, Yu, Xu, Zi‐jun, Sun, Guo‐kang, Zhou, Jing‐dong, Zhang, Ting‐juan, Ma, Ji‐chun, Leng, Jia‐yan, Lin, Jiang, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335806/
https://www.ncbi.nlm.nih.gov/pubmed/34227248
http://dx.doi.org/10.1002/cam4.4085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335806/
https://www.ncbi.nlm.nih.gov/pubmed/34227248
http://dx.doi.org/10.1002/cam4.4085

Ejemplares similares